Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

SOHM Announces Financial Results for 2013

SHMN

SOHM Achieves More Than 65 Percent Growth in Revenue During the Fiscal Year of 2013

BUENA PARK, CA--(Marketwired - Apr 9, 2014) - SOHM, Inc. (PINKSHEETS: SHMN), a generic pharmaceutical manufacturer that produces and markets generic drugs covering all major treatment categories, announced the financial results for the Company's fiscal year 2013, ended December 31, 2013. Revenue in the fiscal the fiscal year of 2013 was $1,959,891 compared to revenue of $1,296,450 during the fiscal year of 2012. This growth of over 65% was achieved due to focused and concerted efforts put in in developing the OTC Generic Drugs business in USA.

Shailesh Shah, President and CEO of SOHM, Inc., stated, "During the year of 2013 SOHM continued to upgrade the manufacturing infrastructure in India as well as kept its focus on developing the business of OTC drugs in child resistant profile pouches through one of its USA based buyer." Mr. Shah Further stated, "Besides continued focus on developing the pouch business through this buyer SOHM is also actively developing the chain store channel for its Skin Care products and OTC Drugs in Travel Pack. The goal is to have nationwide distribution of SOHM products and enlarge its reach to consumer for cost effective therapies that would give a big boost to company revenue and profitability during 2014 and beyond for sustainable basis of growth and innovation."

ABOUT US

SOHM, Inc. is a generic pharmaceutical manufacturer that produces and markets generic drugs covering all major treatment categories. Besides Generic Drugs, SOHM also has manufacturing facilities for Food Supplements and Cosmetics. The Company's global headquarters is located in California, USA, with manufacturing facilities in India. SOHM, Inc. exports generic pharmaceuticals globally, with a focus on distribution in emerging markets in Africa, Latin America, and Southeast Asia. www.sohm.com

SAFE HARBOR STATEMENT

This press release contains statements, which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of SOHM, Inc., and members of their management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully and the ability to complete before-mentioned transactions. The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.

For More Information
Contact Investor Relations
SOHM Inc.
714-522-6700

Tags: